Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 10Meningioma 6Neuroblastoma 5Carcinoid Tumor 5Medulloblastoma 3Paraganglioma 2Oncogenic osteomalacia 2Gastro-enteropancreatic neuroendocrine tumor 2Carcinoma, Neuroendocrine 2von Hippel-Lindau Disease 1Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Prostatic Neoplasms 1Pinealoma 1Pheochromocytoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ganglioneuroma 1Ganglioneuroblastoma 1Familial ependymoma 1

Interventions

Temozolomide 3Leucovorin 3Fluorouracil 3Capecitabine 3pentetreotide 2Everolimus 2Bevacizumab 2veliparib 1vatalanib 1regorafenib 1palbociclib 1lutetium Lu 177 dotatate 1irinotecan sucrosofate 1gallium Ga 68 dotatate 1dehydroftorafur 1Thalidomide 1Sunitinib 1Panobinostat 1Oxaliplatin 1Octreotide 1Magnetic Resonance Spectroscopy 1Irinotecan 1High-Energy Shock Waves 1Doxorubicin 1Bortezomib 1Blood Specimen Collection 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 111-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Somatostatinoma × gallium Ga 68 dotatate × Clear all
NCT01869725 2021-09-22

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

University of Iowa

Phase 2 Completed
68 enrolled 8 charts
CNSEndocrineNET

Medulloblastoma, Neuroblastoma, Somatostatinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡